Clinical trial · Interventional
Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy?
NCT05167916CI-TRIAL-00055642unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective of this prospective study is to evaluate the clinical performance of combined check cystoscopy and urine cytology findings 4 weeks after initial primary complete resection of T1 BC for detection of residual malignancy at repeat biopsy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Outpatient check cytoscopy | Procedure | — | UNRESOLVED |
| Urine cytology | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- T1 Bladder cancer patients
- interventionNames
- Procedure: Outpatient check cytoscopy
- Diagnostic Test: Urine cytology
Primary outcomes (1)
- measure
- Rate of positive repeat biopsy for malignancy
- timeFrame
- 4 weeks
- description
- The primary outcome include evaluation of the clinical performance of combined urine cytology and outpatient check cystoscopy 4 weeks after primary complete resection of T1BC as a predictive tool for possible residual malignancy at repeat biopsy.
Secondary outcomes (1)
- measure
- Tumor recurrence rate
- timeFrame
- 1 year
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients (aged \>18 years) * Patients with primary or recurrent NMIBC for whom complete primary TURBT was done. Exclusion Criteria: * Patients with incomplete resection * Patients with nonurothelial carcinoma or variant histology. * Patient with biopsy proven muscle invasion, or Ta BC.
References
Publications (0)
Data not yet available
No reference posted for this study.